At Breakthrough Haematology, clinical care is informed by active involvement in blood cancer research.
Our doctors contribute to peer-reviewed publications, clinical trial reports and collaborative research across lymphoma, myeloma, CLL and other blood disorders. This academic work helps ensure our patients receive care that reflects current evidence, emerging treatments and international best practice.